SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Shichun Peng, Yilong Ma, Phoebe G. Spetsieris, Paul Mattis, Andrew Feigin, Vijay Dhawan, David Eidelberg, Characterization of disease-related covariance topographies with SSMPCA toolbox: Effects of spatial normalization and PET scanners, Human Brain Mapping, 2013, 34, 6
  2. 2
    A. Berardelli, G. K. Wenning, A. Antonini, D. Berg, B. R. Bloem, V. Bonifati, D. Brooks, D. J. Burn, C. Colosimo, A. Fanciulli, J. Ferreira, T. Gasser, F. Grandas, P. Kanovsky, V. Kostic, J. Kulisevsky, W. Oertel, W. Poewe, J.-P. Reese, M. Relja, E. Ruzicka, A. Schrag, K. Seppi, P. Taba, M. Vidailhet, EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  3. 3
    Raquel C. Gardner, Adam L. Boxer, Andrew Trujillo, Jacob B. Mirsky, Christine C. Guo, Efstathios D. Gennatas, Hilary W. Heuer, Eric Fine, Juan Zhou, Joel H. Kramer, Bruce L. Miller, William W. Seeley, Intrinsic connectivity network disruption in progressive supranuclear palsy, Annals of Neurology, 2013, 73, 4
  4. 4
    Ping Wu, Jian Wang, Shichun Peng, Yilong Ma, Huiwei Zhang, Yihui Guan, Chuantao Zuo, Metabolic brain network in the Chinese patients with Parkinson's disease based on 18F-FDG PET imaging, Parkinsonism & Related Disorders, 2013, 19, 6, 622

    CrossRef

  5. 5
    Laura K. Teune, Remco J. Renken, Deborah Mudali, Bauke M. Jong, Rudi A. Dierckx, Jos B.T.M. Roerdink, Klaus L. Leenders, Validation of parkinsonian disease-related metabolic brain patterns, Movement Disorders, 2013, 28, 4
  6. 6
    David J. Brooks, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  7. 7
    David Brooks, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  8. 8
    Vijay Dhawan, Chris C. Tang, Yilong Ma, Phoebe Spetsieris, David Eidelberg, Abnormal network topographies and changes in global activity: Absence of a causal relationship, NeuroImage, 2012, 63, 4, 1827

    CrossRef

  9. 9
    David J. Brooks, Can imaging separate multiple system atrophy from Parkinson's disease?, Movement Disorders, 2012, 27, 1
  10. 10
    Kathleen L. Poston, David Eidelberg, Functional brain networks and abnormal connectivity in the movement disorders, NeuroImage, 2012, 62, 4, 2261

    CrossRef

  11. 11
    Florian Holtbernd, David Eidelberg, Functional brain networks in movement disorders, Current Opinion in Neurology, 2012, 25, 4, 392

    CrossRef

  12. 12
    Martin Niethammer, David Eidelberg, Metabolic brain networks in translational neurology: Concepts and applications, Annals of Neurology, 2012, 72, 5
  13. 13
    Mario Mascalchi, Alessandra Vella, Roberto Ceravolo, Movement disorders: role of imaging in diagnosis, Journal of Magnetic Resonance Imaging, 2012, 35, 2
  14. 14
    Michael H. Pourfar, Chris C. Tang, Alon Y. Mogilner, Vijay Dhawan, David Eidelberg, Using imaging to identify psychogenic parkinsonism before deep brain stimulation surgery, Journal of Neurosurgery, 2012, 116, 1, 114

    CrossRef

  15. 15
    Sushil Sharma, Manuchair Ebadi, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  16. 16
    S. Lanfranconi, S. Corti, P. Baron, G. Conti, L. Borellini, N. Bresolin, A. Bersano, Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment, Neurology Research International, 2011, 2011, 1

    CrossRef

  17. 17
    Yun Ju Christine Song, Yue Huang, Glenda Margaret Halliday, Clinical correlates of similar pathologies in parkinsonian syndromes, Movement Disorders, 2011, 26, 3
  18. 18
    Phoebe G. Spetsieris, David Eidelberg, Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues, NeuroImage, 2011, 54, 4, 2899

    CrossRef

  19. 19
    Kurt A. Jellinger, Youmans Neurological Surgery, 2011,

    CrossRef

  20. 20
    Kathleen L. Poston, David Eidelberg, 18F-Fluorodeoxyglucose PET in the Evaluation of Parkinson Disease, PET Clinics, 2010, 5, 1, 55

    CrossRef

  21. 21
    S. Hirano, H. Shinotoh, H. Shimada, A. Aotsuka, N. Tanaka, T. Ota, K. Sato, H. Ito, S. Kuwabara, K. Fukushi, T. Irie, T. Suhara, Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia, Brain, 2010, 133, 7, 2058

    CrossRef

  22. 22
    Chris C Tang, Kathleen L Poston, Thomas Eckert, Andrew Feigin, Steven Frucht, Mark Gudesblatt, Vijay Dhawan, Martin Lesser, Jean-Paul Vonsattel, Stanley Fahn, David Eidelberg, Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis, The Lancet Neurology, 2010, 9, 2, 149

    CrossRef

  23. 23
    M. Stamelou, R. de Silva, O. Arias-Carrion, E. Boura, M. Hollerhage, W. H. Oertel, U. Muller, G. U. Hoglinger, Rational therapeutic approaches to progressive supranuclear palsy, Brain, 2010, 133, 6, 1578

    CrossRef

  24. 24
    Chrissa Sioka, Andreas Fotopoulos, Athanassios P. Kyritsis, Recent advances in PET imaging for evaluation of Parkinson’s disease, European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37, 8, 1594

    CrossRef

  25. 25
    Laura K. Teune, Anna L. Bartels, Bauke M. de Jong, Antoon T. M. Willemsen, Silvia A. Eshuis, Jeroen J. de Vries, Joost C. H. van Oostrom, Klaus L. Leenders, Typical cerebral metabolic patterns in neurodegenerative brain diseases, Movement Disorders, 2010, 25, 14
  26. 26
    Katherine L. Possin, Visual spatial cognition in neurodegenerative disease, Neurocase, 2010, 16, 6, 466

    CrossRef

  27. 27
    Chris C. Tang, David Eidelberg, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  28. 28
    Yilong Ma, Chengke Tang, James R. Moeller, David Eidelberg, Abnormal regional brain function in Parkinson's disease: truth or fiction?, NeuroImage, 2009, 45, 2, 260

    CrossRef

  29. 29
    Manuel B. Graeber, Biomarkers for Parkinson's disease, Experimental Neurology, 2009, 216, 2, 249

    CrossRef

  30. 30
    Phoebe G. Spetsieris, Yilong Ma, Vijay Dhawan, David Eidelberg, Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features, NeuroImage, 2009, 45, 4, 1241

    CrossRef

  31. 31
    Andrea Varrone, Susanne Asenbaum, Thierry Borght, Jan Booij, Flavio Nobili, Kjell Någren, Jacques Darcourt, Özlem L. Kapucu, Klaus Tatsch, Peter Bartenstein, Koen Laere, EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2, European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36, 12, 2103

    CrossRef

  32. 32
    David Eidelberg, Metabolic brain networks in neurodegenerative disorders: a functional imaging approach, Trends in Neurosciences, 2009, 32, 10, 548

    CrossRef

  33. 33
    Shigeki Hirano, Thomas Eckert, Toni Flanagan, David Eidelberg, Metabolic networks for assessment of therapy and diagnosis in Parkinson's disease, Movement Disorders, 2009, 24, S2
  34. 34
    Kathleen L. Poston, David Eidelberg, Network biomarkers for the diagnosis and treatment of movement disorders, Neurobiology of Disease, 2009, 35, 2, 141

    CrossRef

  35. 35
    Gregor K. Wenning, Nadia Stefanova, Recent developments in multiple system atrophy, Journal of Neurology, 2009, 256, 11, 1791

    CrossRef

  36. 36
    Kenneth Marek, Danna Jennings, Gilles Tamagnan, John Seibyl, Biomarkers for Parkison's disease: Tools to assess Parkinson's disease onset and progression, Annals of Neurology, 2008, 64, S2
  37. 37
    Erik S. Musiek, Drew A. Torigian, Andrew B. Newberg, Investigation of Nonneoplastic Neurologic Disorders with PET and MRI, PET Clinics, 2008, 3, 3, 317

    CrossRef